Thioredoxin: A multifunctional antioxidant enzyme in kidney, heart and vessels

Current Opinion in Nephrology and Hypertension

Volumn 14, Issue 2, 2005, Pages 149-153

  Yamawaki, Hideyuki ^a,b   Berk, Bradford C ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Antioxidants; Cardiovascular disease; Endothelium; Signal transduction; Smooth muscle

Indexed keywords

ANTIOXIDANT; APOPTOSIS SIGNAL REGULATING KINASE 1; BINDING PROTEIN; GLUTATHIONE DISULFIDE; OXIDOREDUCTASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THIOREDOXIN; THIOREDOXIN REDUCTASE;

ATHEROSCLEROSIS; BLOOD VESSEL; BLOOD VESSEL INJURY; CELL PROLIFERATION; DNA SYNTHESIS; ENZYME ACTIVITY; HEART; HEART DISEASE; HUMAN; HYPERTENSION; KIDNEY; KIDNEY FAILURE; KIDNEY INJURY; NITROSYLATION; NONHUMAN; OXIDATION KINETICS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM;

EID: 15444377306     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200503000-00010     Document Type: Review

References (41)

1. Nordberg J, Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001; 31:1287-1312.
2. Powis G, Briehl M, Oblong J. Redox signalling and the control of cell growth and death. Pharmacol Ther 1995; 68:149-173.
3. Chae HZ, Chung SJ, Rhee SG. Thioredoxin-dependent peroxide reductase from yeast. J Biol Chem 1994; 269:27670-27678.
4. Kang SW, Chae HZ, Seo MS, et al. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 1998; 273:6297-6302.
5. Spyrou G, Enmark E, Miranda-Vizuete A, et al. Cloning and expression of a novel mammalian thioredoxin. J Biol Chem 1997; 272:2936-2941.
6. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, et al. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J 2002; 21:1695-1703.
7. Matthews JR, Wakasugi N, Virelizier JL, et al. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 1992; 20:3821-3830.
8. Hirota K, Matsui M, Iwata S, et al. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA 1997; 94:3633-3638.
9. Powis G, Mustacich D, Coon A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med 2000; 29:312-322.
10. Okuda M, Inoue N, Azumi H, et al. Expression of glutaredoxin in human coronary arteries: its potential role in antioxidant protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21:1483-1487.
11. Nakamura H, Matsuda M, Furuke K, et al. Adult T cell leukemia-derived factor/ human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol Lett 1994; 42:75-80.
12. Schulze PC, De Keulenaer GW, Yoshioka J, et al. Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin. Circ Res 2002; 91:689-695.
13. Takagi Y, Gon Y, Todaka T, et al. Expression of thioredoxin is enhanced in atherosclerotic plaques and during neointima formation in rat arteries. Lab Invest 1998; 78:957-966.
14. Furman C, Rundlof AK, Larigauderie G, et al. Thioredoxin reductase 1 is upregulated in atherosclerotic plaques: specific induction of the promoter in human macrophages by oxidized low-density lipoproteins. Free Radic Biol Med 2004; 37:71-85.
15. Tanito M, Nakamura H, Kwon YW, et al. Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats. Antioxid Redox Signal 2004; 6:89-97.
16. Yamagata K, Tagami M, Ikeda K, et al. Altered gene expressions during hypoxia and reoxygenation in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Neurosci Lett 2000; 284:131-134.
17. Kasuno K, Nakamura H, Ono T, et al. Protective roles of thioredoxin, a redox-regulating protein, in renal ischemia/reperfusion injury. Kidney Int 2003; 64:1273-1282. The authors show that thioredoxin is retained in medullary-tubule ascending limb of the kidney and secreted from proximal tubuli into urine during renal ischemia/ reperfusion. The retention of thioredoxin may have a protective effect against renal ischemia/reperfusion injury.
18. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol Cell Physiol 1996; 271:C1424-C1437.
19. Turoczi T, Chang VW, Engelman RM, et al. Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1. J Mol Cell Cardiol 2003; 35:695-704.
20. Yamamoto M, Yang G, Hong C, et al. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest 2003; 112:1395-1406. The authors show that endogenous thioredoxin is an essential component of the cardiomyocyte antioxidant mechanisms and plays a critical role in regulating oxidative stress in the heart in vivo. Furthermore, inhibiting endogenous thioredoxin in the heart promoted hypertrophy, both under basal conditions and in response to pressure overload through redox-sensitive mechanisms.
21. Aota M, Matsuda K, Isowa N, et al. Protection against reperfusion-induced arrhythmias by human thioredoxin. J Cardiovasc Pharmacol 1996; 27:727-732.
22. Shioji K, Kishimoto C, Nakamura H, et al. Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation 2002; 106:1403-1409.
23. Tao L, Gao E, Bryan NS, et al. Cardioprotective effects of thioredoxin in myocardial ischemia and the reperfusion role of S-nitrosation. Proc Natl Acad Sci USA 2004; 101:11471-11476. The authors show that thioredoxin is taken up by the myocardium and exerts cardioprotective effects that are further potentiated by S-nitrosation.
24. Ichijo H, Nishida E, Irie K, et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997; 275:90-94.
25. Saitoh M, Nishitoh H, Fujii M, et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998; 17:2596-2606.
26. Chen KS, DeLuca HF. Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochim Biophys Acta 1994; 1219:26-32.
27. Nishiyama A, Matsui M, Iwata S, et al. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 1999; 274:21645-21650.
28. Junn E, Han SH, Im JY, et al. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol 2000; 164:6287-6295.
29. Schulze PC, Yoshioka J, Takahashi T, et al. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 2004; 279:30369-30374. These studies implicate reduced thioredoxin activity secondary to TXNIP induction as an important mechanism for vascular oxidative stress in diabetes mellitus.
30. Kobayashi T, Uehara S, Ikeda T, et al. Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells. Kidney Int 2003; 64:1632-1642.
31. Yoshioka J, Schulze PC, Cupesi M, et al. Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity. Circulation 2004; 109:2581-2586. In this paper it is shown that activation of thioredoxin contributes to the development of pressure-overload cardiac hypertrophy, demonstrating the dual function of thioredoxin as both an antioxidant and a signaling protein. The results also support the emerging concept that TXNIP is a critical regulator of biomechanical signaling.
32. Yamawaki H and Berk BC. Thioredoxin: a multifunctional antioxidant enzyme in kidney, heart and vessels. J Clin Invest (in press).
33. Yamawaki H, Lehoux S, Berk BC. Chronic physiological shear stress inhibits tumor necrosis factor-induced proinflammatory responses in rabbit aorta perfused ex vivo. Circulation 2003; 108:1619-1625.
34. Watson WH, Pohl J, Montfort WR, et al. Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J Biol Chem 2003; 278:33408-33415.
35. Weichsel A, Gasdaska JR, Powis G, et al. Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer. Structure 1996; 4:735-751.
36. Stamler JS, Lamas S, Fang FC. Nitrosylation: the prototypic redox-based signaling mechanism. Cell 2001; 106:675-683.
37. Haendeler J, Hoffmann J, Tischler V, et al. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol 2002; 4:743-749.
38. Sumbayev VV. S-nitrosylation of thioredoxin mediates activation of apoptosis signal-regulating kinase 1. Arch Biochem Biophys 2003; 415:133-136.
39. Haendeler J, Hoffmann J, Zeiher AM, et al. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endotheliat cells: A novel vasculoprotective function of statins. Circulation 2004; 110:856-861. In this report statin-mediated S-nitrosylation of thioredoxin enhanced the enzymatic activity of thioredoxin, resulting in a significant reduction in intracellular ROS.
40. Casagrande S, Bonetto V, Fratelli M, et al. Glutathionylation of human thioredoxin: a possible crosstalk between the glutathione and thioredoxin systems. Proc Natl Acad Sci USA 2002; 99:9745-9749.
41. Adachi T, Pimentel DR, Heibeck T, et al. S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem 2004; 279:29857-29862.